Isoliquiritigenin represses the pro-fibrotic TGF-β/smad2 signaling and nuclear enriched abundant transcript 1 (NEAT1) in oral submucous fibrosis. [PDF]
Tseng CS +5 more
europepmc +1 more source
Decoding the therapeutic promise of Solanum trilobatum in oral submucous fibrosis: a network pharmacology, docking, and bioactivity study. [PDF]
Balasubramaniam AM +6 more
europepmc +1 more source
Postoperative conductive hearing loss after full-arch-implantation surgery under general anesthesia in an oral submucous fibrosis patient: A case report. [PDF]
Wang HC, Tsai FC, Wu CC, Fang CY.
europepmc +1 more source
New frontiers in oral submucous fibrosis: The promise of collagen based interventions. [PDF]
Lamba K +5 more
europepmc +1 more source
Comparative Evaluation of Serum Homocysteine in Patients with Oral Submucous Fibrosis and Healthy Controls. [PDF]
Shastri S +5 more
europepmc +1 more source
Global expert consensus on oral submucous fibrosis: Standardizing care, surveillance, and prevention strategies. [PDF]
Ramani P +11 more
europepmc +1 more source
Role of hyperbaric oxygen therapy in oral submucous fibrosis: a randomized comparative study from India. [PDF]
Sah R +8 more
europepmc +1 more source
Evaluating Hearing Impairment in Different Histopathological Grades of Oral Submucous Fibrosis: An Audiometric Analysis. [PDF]
Jha R +5 more
europepmc +1 more source
Clinical and histopathological manifestations of snus use in Germany: parallels to betel nut-related oral submucous fibrosis in Asia. [PDF]
Greber L +4 more
europepmc +1 more source

